Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients

被引：30

作者：

Boekel, L. ^{[1
]}

Wolbink, G. J. ^{[1
,2
,3
]}

机构：

[1] Amsterdam Rheumatol & Immunol Ctr, Dept Rheumatol, Reade, Locat Dr Jan van Breemenstr, NL-1056 AB Amsterdam, Netherlands

[2] Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands

[3] Acad Med Ctr, Landsteiner Lab, Amsterdam, Netherlands

来源：

LANCET RHEUMATOLOGY | 2022年 / 4卷 / 03期

关键词：

D O I：

10.1016/S2665-9913(21)00418-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E154 / E155

页数：2

共 10 条

[1] Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative [J].

Andersen, Kathleen M. ;

Bates, Benjamin A. ;

Rashidi, Emaan S. ;

Olex, Amy L. ;

Mannon, Roslyn B. ;

Patel, Rena C. ;

Singh, Jasvinder ;

Sun, Jing ;

Auwaerter, Paul G. ;

Ng, Derek K. ;

Segal, Jodi B. ;

Garibaldi, Brian T. ;

Mehta, Hemalkumar B. ;

Alexander, G. Caleb .

LANCET RHEUMATOLOGY, 2022, 4 (01) :E33-E41

[2] Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies [J].

Boekel, Laura ;

Steenhuis, Maurice ;

Hooijberg, Femke ;

Besten, Yaelle R. ;

van Kempen, Zoe L. E. ;

Kummer, Laura Y. ;

van Dam, Koos P. J. ;

Stalman, Eileen W. ;

Vogelzang, Erik H. ;

Cristianawati, Olvi ;

Keijzer, Sofie ;

Vidarsson, Gestur ;

Voskuyl, Alexandre E. ;

Wieske, Luuk ;

Eftimov, Filip ;

van Vollenhoven, Ronald ;

Kuijpers, Taco W. ;

van Ham, S. Marieke ;

Tas, Sander W. ;

Killestein, Joep ;

Boers, Maarten ;

Nurmohamed, Michael ;

Rispens, Theo ;

Wolbink, Gertjan .

LANCET RHEUMATOLOGY, 2021, 3 (11) :E778-E788

[3] Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases [J].

Cook, Claire ;

Patel, Naomi J. ;

D'Silva, Kristin M. ;

Hsu, Tiffany Y-T ;

Dilorio, Michael ;

Prisco, Lauren ;

Martin, Lily W. ;

Vanni, Kathleen ;

Zaccardelli, Alessandra ;

Todd, Derrick ;

Sparks, Jeffrey A. ;

Wallace, Zachary Scott .

ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (02) :289-291

[4]

Horby PW., 2021, CASIRIVIMAB IMDEVIMA, DOI 10.1101/2021.06.15.21258542

[5] Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study [J].

Jyssum, Ingrid ;

Kared, Hassen ;

Tran, Trung T. ;

Tveter, Anne T. ;

Provan, Sella A. ;

Sexton, Joseph ;

Jorgensen, Kristin K. ;

Jahnsen, Jorgen ;

Kro, Grete B. ;

Warren, David J. ;

Vaage, Eline B. ;

Kvien, Tore K. ;

Nissen-Meyer, Lise-Sofie H. ;

Anderson, Ane Marie ;

Grodeland, Gunnveig ;

Haavardsholm, Espen A. ;

Vaage, John Torgils ;

Mjaaland, Siri ;

Syversen, Silje Watterdal ;

Lund-Johansen, Fridtjof ;

Munthe, Ludvig A. ;

Goll, Guro Lovik .

LANCET RHEUMATOLOGY, 2022, 4 (03) :E177-E187

[6] Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study [J].

Moor, Matthias B. ;

Suter-Riniker, Franziska ;

Horn, Michael P. ;

Aeberli, Daniel ;

Amsler, Jennifer ;

Moller, Burkhard ;

Njue, Linet M. ;

Medri, Cesare ;

Angelillo-Scherrer, Anne ;

Borradori, Luca ;

Radonjic-Hoesli, Susanne ;

Jafari, S. Morteza Seyed ;

Chan, Andrew ;

Hoepner, Robert ;

Bacher, Vera Ulrike ;

Mani, Laila-Yasmin ;

Iype, Joseena Mariam ;

Hirzel, Cedric ;

Maurer, Britta ;

Sidler, Daniel .

LANCET RHEUMATOLOGY, 2021, 3 (11) :E789-E797

[7] SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity [J].

Mrak, Daniel ;

Tobudic, Selma ;

Koblischke, Maximilian ;

Graninger, Marianne ;

Radner, Helga ;

Sieghart, Daniela ;

Hofer, Philipp ;

Perkmann, Thomas ;

Haslacher, Helmuth ;

Thalhammer, Renate ;

Winkler, Stefan ;

Blueml, Stephan ;

Stiasny, Karin ;

Aberle, Judith H. ;

Smolen, Josef S. ;

Heinz, Leonhard X. ;

Aletaha, Daniel ;

Bonelli, Michael .

ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (10) :1345-1350

[8] Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis [J].

Simpson-Yap, Steve ;

De Brouwer, Edward ;

Kalincik, Tomas ;

Rijke, Nick ;

Hillert, Jan A. ;

Walton, Clare ;

Edan, Gilles ;

Moreau, Yves ;

Spelman, Tim ;

Geys, Lotte ;

Parciak, Tina ;

Gautrais, Clement ;

Lazovski, Nikola ;

Pirmani, Ashkan ;

Ardeshirdavanai, Amin ;

Forsberg, Lars ;

Glaser, Anna ;

McBurney, Robert ;

Schmidt, Hollie ;

Bergmann, Arnfin B. ;

Braune, Stefan ;

Stahmann, Alexander ;

Middleton, Rodden ;

Salter, Amber ;

Fox, Robert J. ;

van der Walt, Anneke ;

Butzkueven, Helmut ;

Alroughani, Raed ;

Ozakbas, Serkan ;

Rojas, Juan, I ;

van der Mei, Ingrid ;

Nag, Nupur ;

Ivanov, Rumen ;

do Olival, Guilherme Sciascia ;

Dias, Alice Estavo ;

Magyari, Melinda ;

Brum, Doralina ;

Mendes, Maria Fernanda ;

Alonso, Ricardo N. ;

Nicholas, Richard S. ;

Bauer, Johana ;

Chertcoff, Anibal Sebastian ;

Zabalza, Anna ;

Arrambide, Georgina ;

Fidao, Alexander ;

Comi, Giancarlo ;

Peeters, Liesbet .

NEUROLOGY, 2021, 97 (19) :E1870-E1885

[9] Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate? [J].

van Kempen, Z. L. E. ;

Wieske, L. ;

Stalman, E. W. ;

Kummer, L. Y. L. ;

van Dam, P. J. ;

Volkers, A. G. ;

Boekel, L. ;

Toorop, A. A. ;

Strijbis, E. M. M. ;

Tas, S. W. ;

Wolbink, G. J. ;

Lowenberg, M. ;

van Sandt, C. ;

ten Brinke, A. ;

Verstegen, N. J. M. ;

Steenhuis, M. ;

Kuijpers, T. W. ;

van Ham, S. M. ;

Rispens, T. ;

Eftimov, F. ;

Killestein, J. .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57

[10]

Wilhelm A., 2021, medRxiv, DOI [10.1101/2021.12.07.21267432, DOI 10.1101/2021.12.07.21267432]

← 1 →